Healthcare CMO Market to Witness Astonishing Growth by 2027

1
Healthcare CMO Market
Healthcare CMO Market to 2027 - Global Analysis
and Forecasts By Service (Pharmaceutical Contract
Manufacturing Services and Medical Device
Contract Manufacturing Services), and Geography
2
Market Scope
Healthcare CMO Market

• The global healthcare CMO market accounted to US
  80,479.4 in 2018 and is expected to grow at a
  CAGR of 12.2 during the forecast period 2019 -
  2027, to account to US 223,355.6 Mn by 2027.
• Asia-Pacific is the fastest growing geographic
  market and it is anticipated to be the third
  largest revenue contributor throughout the
  forecast period. Asia Pacific is recognized as an
  emerging market for the pharmaceutical and
  biopharmaceutical industry across the world. The
  growth is defined by the cost effective
  manufacturing of the pharmaceutical products and
  rising healthcare expenditures by the various
  countries in the region.

3
Market Segments
Healthcare CMO Market
4
Factors Contributing to Market Growth
Healthcare CMO Market

• Increasing Inclination of Pharmaceutical and
  Medical Device Manufacturers Towards Outsourcing
• Rising Demand in Developing Regions
• The developing regions such as Asia Pacific and
  Middle East, Africa and Latin America are growing
  dynamically in the biotechnology and
  pharmaceutical sectors. The governments of the
  respective countries in these regions are
  supporting through various initiatives, funding,
  programs and conferences. The growth of the
  pharmaceutical and biotechnology is driven by the
  economic, demographic development, rising
  healthcare expenditures, and improving
  public-private healthcare funding among the
  others. 

5
Healthcare CMO Market
Strategic Insights
Mergers and agreements were observed as the most
adopted strategy in global healthcare CMO
industry. Few of the recent market consolidations
are listed below   2018 In October, 2018,
Recipharm acquired Sanofis inhalation contract
manufacturing business including a manufacturing
facility located in Holmes Chapel, UK to expand
its full service offering to include specialist,
in-demand capabilities. 2017 In February,
2017, Catalent Pharma Solutions acquired Accucaps
Industries Limited to expand Softgel development
and manufacturing capabilities and capacity in
Canada. 2015 In May 2015, Lonza and Nikon
signed a collaboration in the field of cell and
gene therapy manufacturing in Japan.
For more details, get sample PDF copy
https//www.theinsightpartners.com/sample/TIPRE000
03263/
6
Leading Players
Healthcare CMO Market

• Royal DSM
• Catalent, Inc
• Boehringer Ingelheim International GmbH
• Recipharm AB (publ)
• Fareva
• Lonza
• Piramal Enterprises Ltd
• Dr. Reddys Laboratories Ltd.
• Almac Group
• FAMAR Health Care Services

7

A report titled Healthcare CMO Market -
Opportunities and Forecasts, 2019 2027 has
been recently published by The Insight Partners.
The report makes close observations of pipeline
structure for end-to-end market around the world.
It makes an in-depth analysis of current trends,
drivers, and restraining factors that affect
financial ratios relevant to the industry.
Company profiles for key vendors in business
builds a comprehensive picture of profitable
opportunities from stakeholders perspective.

To know more about the Healthcare CMO Market -
Opportunities and Forecasts, 2019 2027 report
https//www.theinsightpartners.com/reports/healthc
are-cmo-market
Follow us on
Thank You